 |
|
Perspective: Is It Time to Rename MSC (Mesenchymal Stem Cells/Medicinal Signaling Cells) with a Name that Reflects Their Combined In Vivo Functions and Their In Vitro Abilities?—Possibly “Pluripotent Mesenchymal Regulatory Cells (PMRC)”
David A. Hart
J. Biomed. Sci. Eng. Vol.14 No.8, August 31, 2021 DOI: 10.4236/jbise.2021.148027
The Use of Artificial Intelligence on Segmental Volumes, Constructed from MRI and CT Images, in the Diagnosis and Staging of Cervical Cancers and Thyroid Cancers: A Study Protocol for a Randomized Controlled Trial
Tudor Florin Ursuleanu,
Andreea Roxana Luca,
Liliana Gheorghe,
Roxana Grigorovici,
Stefan Iancu,
Maria Hlusneac,
Cristina Preda,
Alexandru Grigorovici
J. Biomed. Sci. Eng. Vol.14 No.6, June 28, 2021 DOI: 10.4236/jbise.2021.146025
Optimization of Maturation of Radio-Cephalic Arteriovenous Fistula Using a Model Relating Energy Loss Rate and Vascular Geometric Parameters
Yang Yang,
Nellie Della Schiava,
Pascale Kulisa,
Mahmoud El Hajem,
Benyebka Bou-Saïd,
Serge Simoëns,
Patrick Lermusiaux
J. Biomed. Sci. Eng. Vol.14 No.6, June 25, 2021 DOI: 10.4236/jbise.2021.146023